(Q37338979)

19 August 2017

1 reference

title

Antiviral strategies (English)

1 reference

19 August 2017

author

Hans-Georg Kräusslich

series ordinal

2

object named as

Hans-Georg Kräusslich

1 reference

19 August 2017

B Müller

1

1 reference

19 August 2017

publication date

1 January 2009

1 reference

Handbook of experimental pharmacology

19 August 2017

published in

1 reference

19 August 2017

issue

189

1 reference

19 August 2017

page(s)

1-24

1 reference

SARS: systematic review of treatment effects

19 August 2017

cites work

1 reference

12 December 2020

Identification of host proteins required for HIV infection through a functional genomic screen

1 reference

12 December 2020

HIV-1 assembly and budding as targets for drug discovery.

1 reference

12 December 2020

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

1 reference

12 December 2020

1 reference

12 December 2020

Ribavirin--current status of a broad spectrum antiviral agent

1 reference

12 December 2020

HIV-1 coreceptors and their inhibitors

1 reference

12 December 2020

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

1 reference

12 December 2020

Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila

1 reference

12 December 2020

CARD games between virus and host get a new player

1 reference

12 December 2020

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

12 December 2020

Viruses know it all: new insights into IFN networks

1 reference

12 December 2020

Virus membrane-fusion proteins: more than one way to make a hairpin

1 reference

12 December 2020

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

1 reference

12 December 2020

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids

1 reference

12 December 2020

A history of the discovery and clinical application of antiviral drugs

1 reference

12 December 2020

Systems biology of virus entry in mammalian cells

1 reference

12 December 2020

Gene therapy for HIV infection: what does it need to make it work?

1 reference

12 December 2020

Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.

1 reference

12 December 2020

(S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity

1 reference

12 December 2020

Late budding domains and host proteins in enveloped virus release

1 reference

12 December 2020

Silencing of HIV-1 with RNA interference: a multiple shRNA approach

1 reference

12 December 2020

A peptide inhibitor of HIV-1 assembly in vitro

1 reference

12 December 2020

The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax

1 reference

12 December 2020

Retroviral restriction by APOBEC proteins

1 reference

12 December 2020

Infection of a human hepatoma cell line by hepatitis B virus

1 reference

12 December 2020

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

1 reference

12 December 2020

Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones.

1 reference

12 December 2020

Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein

1 reference

12 December 2020

Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase

1 reference

12 December 2020

Gene therapy. Intracellular immunization

1 reference

12 December 2020

Susceptibility to two strains of Friend leukemia virus in mice

1 reference

12 December 2020

Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana

1 reference

12 December 2020

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

1 reference

12 December 2020

Gene silencing as an adaptive defence against viruses

1 reference

12 December 2020

Neuraminidase inhibitors as antiviral agents

1 reference

12 December 2020

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine

1 reference

12 December 2020

RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides

1 reference

12 December 2020

Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid

1 reference

12 December 2020

RNA interference is an antiviral defence mechanism in Caenorhabditis elegans

1 reference

12 December 2020

Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis

1 reference

12 December 2020

Expression of animal virus genomes

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

A viral microRNA functions as an orthologue of cellular miR-155

1 reference

12 December 2020

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

12 December 2020

Acyclic nucleoside phosphonates: a key class of antiviral drugs

1 reference

12 December 2020

RNA interference as an antiviral approach: targeting HIV-1.

1 reference

12 December 2020

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 December 2020

PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)

1 reference

12 December 2020

Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Aptamers come of age - at last

1 reference

12 December 2020

Interactions between host and viral genomes in mouse leukemia

1 reference

12 December 2020

RNA interference directs innate immunity against viruses in adult Drosophila

1 reference

12 December 2020

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

1 reference

12 December 2020

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

12 December 2020

A cell-penetrating helical peptide as a potential HIV-1 inhibitor

1 reference

12 December 2020

Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns

1 reference

12 December 2020

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

12 December 2020

TRIM family proteins: retroviral restriction and antiviral defence

1 reference

12 December 2020

Peginterferon and ribavirin for chronic hepatitis C.

1 reference

12 December 2020

RNA interference: its use as antiviral therapy.

1 reference

12 December 2020

Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1.

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide

1 reference

12 December 2020

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

1 reference

12 December 2020

Antiviral innate immunity pathways.

1 reference

12 December 2020

Mechanisms of enveloped RNA virus budding

1 reference

12 December 2020

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

1 reference

12 December 2020

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

1 reference

12 December 2020

10.1007/978-3-540-79086-0_1

Identifiers

DOI

1 reference

19 August 2017

1 reference